Indications for use of Lactofiltrum are:

Violations of the intestinal microflora (intestinal dysbiosis), including as a result of antibiotic therapy; in the complex therapy of irritable bowel syndrome, hepatitis and liver cirrhosis; allergic diseases (atopic dermatitis, urticaria), bacterial vaginosis (vaginal dysbiosis).

  Composition:

Active substances: hydrolytic lignin (in terms of dry matter) 355 mg, lactulose (in terms of 100% substance) 120 mg.

  Pharmachologic effect:

The pharmacological action of the drug is due to the properties that make up the active ingredients - lignin and lactulose. Hydrolysis lignin is a natural enterosorbent consisting of products of hydrolysis of wood components, has a high sorbing activity and nonspecific detoxification effect. Binds in the intestine and removes from the body pathogenic bacteria and bacterial toxins, drugs, heavy metal salts, alcohol, allergens, as well as excess of certain metabolic products, including bilirubin, cholesterol, histamine, serotonin, urea, and other metabolites responsible for the development endogenous toxicosis. Non-toxic, not absorbed, completely excreted from the intestine within 24 hours. Lactulose is a synthetic disaccharide, the molecule of which consists of galactose and fructose residues. Lactulose in the stomach and upper intestines is not absorbed or hydrolyzed. The lactulose released from tablets in the large intestine as a substrate is fermented by the normal intestinal microflora, stimulating the growth of bifidobacteria and lactobacilli. As a result of hydrolysis of lactulose in the large intestine, organic acids are formed lactic, acetic and formic, which suppress the growth of pathogenic microorganisms and, as a result, reduce the production of nitrogen-containing toxic substances. The described process leads to an increase in osmotic pressure in the lumen of the large intestine and stimulation of peristalsis. The complex action of the drug is aimed at normalizing the microbiocenosis of the large intestine and reducing the intensity of endogenous toxic conditions. The use of the drug in the complex therapy of bacterial vaginosis (vaginal dysbiosis) leads to an increase in the effectiveness of therapy, including an increase in the number of lactobacilli in the vagina, as well as effective suppression of the growth of opportunistic flora.